electroCore (ECOR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
If you are looking for stocks that are well positioned to maintain their recent uptrend, electroCore (ECOR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
ElectroCore, Inc.'s promising growth and potential in the medical device industry makes it a strong buy with a $43 per share valuation. Learn more on ECOR stock here.
PR NewswireNEW YORK, Jan. 7, 2025
NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp
electroCore Granted Five New U.S. Patents
ROCKAWAY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medi
Shares of electroCore Inc (ECOR) fell 4.53% in mid-day trading on Jan 1. The stock reached an intraday low of $16.05, before recovering slightly to $16.21,
Shares of electroCore Inc (ECOR) fell 5.36% in mid-day trading on Dec 31. The stock reached an intraday low of $16.07, down from its previous close of $16.98.
PR NewswireNEW YORK, Dec. 23, 2024
NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co
/PRNewswire/ -- DelveInsight's Nerve Repair and Regeneration Market Insights report provides the current and forecast market analysis, individual leading nerve...
Federal securities filings continued to slow during the second half of 2021. The volume of new securities cases filed in 2021 fell by 36% compared to 2020, and 51% compared to 2019. Nonetheless, federal and state securities laws continue to develop in the courts.